As part of an ongoing commitment to strengthening clinical research standards across Africa, Pharmalys participated in the CECaBI II workshop, held on April 24 -25, 2025, in Abidjan, Côte d’Ivoire. The event was a key milestone in clinical research capacity building in West Africa, bringing together stakeholders from various sectors to exchange knowledge on clinical trials, Good Clinical Practice (GCP), and research ethics.
Dr. Karim Bagaté, Pharmalys’ Director of Clinical Operations and Safety, chaired the stakeholders consultation meeting in collaboration with the Institut Pasteur de Paris. His participation in the workshop was an important part of the discussions on strengthening Côte d’Ivoire’s clinical research infrastructure and ‘opening up job opportunities for young graduates in medicine, pharmacy, and science’.
The CECaBI II project involves collaboration between key institutions such as the National Ethics Committee of Life and Health Sciences (CNESVS), the Ivorian Pharmaceutical Regulatory Authority (AIRP), EthixPERT, Institut Pasteur de Paris, and the National Health Research Ethics Committee of Senegal. The collaboration between these organisations is key to ensuring that Côte d’Ivoire has a solid foundation for conducting clinical trials that are ethical, transparent, and scientifically rigorous.
Through the CECaBI II project, the focus is placed on improving training for professionals and enhancing the regulatory environment to support high-quality research practices. The outcome of the project is expected to be a meaningful step forward in addressing the healthcare challenges in Côte d’Ivoire and in building a more sustainable clinical research landscape across West Africa.
For more information about Pharmalys’ commitment to capacity building in clinical research, click here.
